| Patent | Date |
|---|
Use Of Bacillus Amyloliquefaciens And/or Bacillus Subtilis For The Enhancement Of Active Probiotic Compositions Or For The Activation Of Inactive Probiotic Compositions, Compositions Thus Obtained, And Related Method
App 20220160794 - FIORUCCI; Stefano | 2022-05-26 |
Isoxazole as FXR receptor agonists
Grant 11,332,450 - Zampella , et al. May 17, 2 | 2022-05-17 |
Treatment Of Fibrosis Using Fxr Ligands
App 20210346400 - FIORUCCI; Stefano ; et al. | 2021-11-11 |
Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases
Grant 11,117,926 - Zampella , et al. September 14, 2 | 2021-09-14 |
Isoxazole as FXR Receptor Agonists
App 20210269409 - Zampella; Angela ; et al. | 2021-09-02 |
Treatment of fibrosis using FXR ligands
Grant 10,987,362 - Fiorucci , et al. April 27, 2 | 2021-04-27 |
Treatment Of Fibrosis Using Fxr Ligands
App 20200397803 - Fiorucci; Stefano ; et al. | 2020-12-24 |
Treatment Of Fibrosis Using Fxr Ligands
App 20200197414 - Fiorucci; Stefano ; et al. | 2020-06-25 |
Cholane Derivatives For Use In The Treatment And/or Prevention Of Fxr And Tgr5/gpbar1 Mediated Diseases
App 20190352328 - Zampella; Angela ; et al. | 2019-11-21 |
Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases
Grant 10,407,462 - Zampella , et al. Sept | 2019-09-10 |
Treatment of fibrosis using FXR ligands
Grant 10,258,633 - Fiorucci , et al. | 2019-04-16 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 9,763,964 - Pellicciari , et al. September 19, 2 | 2017-09-19 |
Cholane Derivatives For Use In The Treatment And/or Prevention Of Fxr And Tgr5/gpbar1 Mediated Diseases
App 20170190731 - Zampella; Angela ; et al. | 2017-07-06 |
Treatment Of Fibrosis Using Fxr Ligands
App 20170165277 - Fiorucci; Stefano ; et al. | 2017-06-15 |
Treatment of fibrosis using FXR ligands
Grant 9,498,484 - Fiorucci , et al. November 22, 2 | 2016-11-22 |
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions
App 20150359805 - Pellicciari; Roberto ; et al. | 2015-12-17 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 9,090,652 - Pellicciari , et al. July 28, 2 | 2015-07-28 |
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions
App 20140057886 - Pellicciari; Roberto ; et al. | 2014-02-27 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 8,546,365 - Pellicciari , et al. October 1, 2 | 2013-10-01 |
Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatment Of FXR-Mediated Diseases Or Conditions
App 20120283234 - Pellicciari; Roberto ; et al. | 2012-11-08 |
Derivatives of 4- or 5-aminosalicylic acid
Grant 8,114,858 - Wallace , et al. February 14, 2 | 2012-02-14 |
Derivatives of 4- or 5-aminosalicylic acid
Grant 8,114,857 - Wallace , et al. February 14, 2 | 2012-02-14 |
Derivatives Of 4- Or 5-aminosalicylic Acid
App 20110130368 - WALLACE; JOHN L. ; et al. | 2011-06-02 |
Derivatives Of 4- Or 5-aminosalicylic Acid
App 20110098257 - WALLACE; JOHN L. ; et al. | 2011-04-28 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 7,932,244 - Pellicciari , et al. April 26, 2 | 2011-04-26 |
Derivatives of 4- or 5-aminosalicylic acid
Grant 7,910,568 - Wallace , et al. March 22, 2 | 2011-03-22 |
Derivatives of 4- or 5-aminosalicylic acid
Grant 7,879,827 - Wallace , et al. February 1, 2 | 2011-02-01 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 7,858,608 - Pellicciari , et al. December 28, 2 | 2010-12-28 |
Bile Acid Derivatives As Fxr Ligands For The Prevention Or Treatment Of Fxr-mediated Diseases Or Conditions
App 20100063018 - Pellicciari; Roberto ; et al. | 2010-03-11 |
Derivatives Of 4- Or 5-aminosalicylic Acid
App 20090233886 - Wallace; John L. ; et al. | 2009-09-17 |
Derivatives of 4- or 5-aminosalicylic acid
Grant 7,498,355 - Wallace , et al. March 3, 2 | 2009-03-03 |
Derivaitves of 4-Or 5-Aminosalicylic Acid
App 20080207564 - Wallace; John L. ; et al. | 2008-08-28 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
App 20080182832 - Pellicciari; Roberto ; et al. | 2008-07-31 |
Treatment and prevention of intestinal fibrosis
App 20080119439 - Parkinson; John ; et al. | 2008-05-22 |
Derivatives of 4- or 5-aminosalicylic acid
App 20070197479 - Wallace; John L. ; et al. | 2007-08-23 |
Modulation of MDL-1 activity for treatment of inflammatory disease
App 20070179094 - Faulds; Daryl ; et al. | 2007-08-02 |
Derivatives of 4- or 5-aminosalicylic acid
App 20060270635 - Wallace; John L. ; et al. | 2006-11-30 |
Method of reducing drug-induced adverse side effects in a patient
App 20060252670 - Fiorucci; Stefano ; et al. | 2006-11-09 |
Treatment of fibrosis using FXR ligands
App 20060069070 - Fiorucci; Stefano ; et al. | 2006-03-30 |
| 